Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-12

Clinical Trial Update: A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride [Phase 2]

View source ↗

Summary

Phase 2 dose-response trial of midodrine hydrochloride at 5 mg and 10 mg for orthostatic hypotension, including individuals with spinal cord injury; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Midodrine (Midodrine)

Snippet

Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Orthostatic Hypotension, Spinal Cord Injury | Phase 2 | Status: COMPLETED | Results posted: 2015-05-12